Twist Bioscience Reports First Quarter Fiscal 2019 Financial Results and Highlights Commercial and Operational Progress

Go back to Twist Bioscience Reports First Quarter Fiscal 2019 Financial Results and Highlights Commercial and Operational Progress

Twist Bioscience Corporation (TWST) Misses Q1 EPS by 33c, Revenues Beat; Offers FY19 Revenue Outlook

February 7, 2019 4:31 PM EST

Twist Bioscience Corporation (NASDAQ: TWST) reported Q1 EPS of ($1.18), $0.33 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $11.5 million versus the consensus estimate of $9.73 million.

Reports Record Revenue of $11.5 Million for First Quarter of Fiscal 2019 Increasing Orders Show Substantial Growth... More